GENE ONLINE|News &
Opinion
Blog

Bladder Cancer
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
An Enzyme that Defends Against Viruses Could Double Cancer Mutations
2023-01-06
FDA Rejects Sesen Bio’s Bladder Cancer Drug Application, Asks Additional Data
2021-08-16
AstraZeneca Voluntarily Withdraws Checkpoint Inhibitor Approved for Bladder Cancer Indication
2021-02-25
Bavencio Bags FDA Approval as First-line Maintenance Treatment for Urothelial Carcinoma
2020-07-05
R&D
ASCO 2020: Maintenance Therapy with Avelumab Post-Chemo Improves Overall Survival of Bladder Cancer Patients
2020-05-29
How Can Data Science Help Fighting Against Prostate Cancer? Interview with Genomic Scientist Dr. Mohamed Alshalalfa
2019-05-30
LATEST
Trump’s Move to Ditch the WHO Again: Day 1 Sees a Slew of Executive Orders Signed Off
2025-01-21
Cecile Richards’s Battle with Glioblastoma
2025-01-21
$810 Million Turned Into a Rare Disease Revolution with Japan’s Nippon Shinyaku’s and USA’s REGENXBIO’s Partnership
2025-01-21
Neuro, Pain, and Cancer Top the List at JPM 2025 Healthcare Conference
2025-01-17
ZYN Nicotine Pouches Receive FDA Marketing Authorization
2025-01-17
Virginia’s Insurance Marketplace Extends Open Enrollment Deadline: A Detailed Report
2025-01-16
2025 Starts with a Jolt: Layoffs Hit the Life Sciences Industry Ahead of JPM
2025-01-16
EVENT
2025-02-05
Precision Medicine World Conference 2025
Santa Clara, California
2025-02-19
Healthcare Conference Taipei 2025
Taipei, Taiwan
2025-03-17
BIO-Europe Spring 2025
Milan, Italy
2025-04-21
World Vaccine Congress 2025
Washington, U.S.A
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
Scroll to Top